Daxor Corporation (DXR)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $49.51M
Last updated: Nov 17, 2026 at 10:57 AM ET
Daxor Corporation (DXR) Financials: Revenue, Profit and Cash Flow
Daxor reported revenue of $503.42K for the fiscal year ended Dec 31, 2025, down 76.4% from the year before. That year, net income was $9.17M with a net margin of 1821.5%, operating cash flow was -$604.42K and free cash flow was -$604.42K. The quarter ended Jun 30, 2026 had revenue of $23.02K and net income of -$3.31M.
Revenue and Margins
Over the 9 years to Dec 2025, revenue fell from $1.84M, a compound annual decline of 13.4%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $503.42K | -76.4% | 37.5% | 1824.7% | 1821.5% |
| Dec 2024 | $2.13M | -93.8% | 100.0% | 29.2% | 25.2% |
| Dec 2023 | $34.59M | +448.2% | 99.5% | 1.0% | 0.8% |
| Dec 2022 | $6.31M | +8.4% | 100.0% | 83.2% | 82.1% |
| Dec 2021 | $5.82M | N/A | 100.0% | 81.6% | 81.6% |
| Dec 2020 | -$996.30K | N/A | N/A | N/A | N/A |
| Dec 2019 | -$114.99K | N/A | N/A | N/A | N/A |
| Dec 2018 | -$918.45K | N/A | N/A | N/A | N/A |
| Dec 2017 | -$1.01M | -155.1% | N/A | N/A | N/A |
| Dec 2016 | $1.84M | N/A | 84.9% | 80.0% | 79.3% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 1609.8% from the year before. In the quarter ended Jun 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $503.42K | $2.13M | $34.59M | $6.31M | $5.82M | -$996.30K | -$114.99K | -$918.45K | -$1.01M | $1.84M |
| Cost of revenue | $314.68K | N/A | $177.07K | $1.09M | $1.00M | $562.83K | $488.65K | $346.61K | $193.97K | $276.75K |
| Gross profit | $188.74K | $2.13M | $34.41M | $6.31M | $5.82M | -$996.30K | -$114.99K | -$918.45K | -$1.01M | $1.56M |
| Operating income | $9.19M | $621.42K | $329.74K | $5.25M | $4.75M | -$1.73M | -$495.70K | -$1.10M | -$1.14M | $1.47M |
| Net income | $9.17M | $536.33K | $280.64K | $5.18M | $4.75M | -$1.71M | -$495.70K | -$885.77K | -$1.24M | $1.46M |
| EBITDA | $9.19M | $2.06M | $1.12M | $5.25M | $4.75M | -$1.73M | -$495.70K | -$1.10M | -$1.14M | $1.47M |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.02K | $131.85K | $18.35K | $695.31K | $71.76K | $35.88K | $82.45K | $41.22K | $80.97K | $40.49K | $96.40K | $48.20K |
| Gross profit | -$60.33K | -$104.64K | $18.35K | $620.66K | $71.76K | $35.88K | $82.45K | $41.22K | $80.97K | $40.49K | $96.40K | $48.20K |
| Operating income | -$3.31M | $9.54M | -$269.50K | $2.21M | -$297.55K | -$148.78K | $3.06M | -$210.79K | -$366.46K | -$183.23K | -$624.21K | -$312.10K |
| Net income | -$3.31M | $9.54M | -$369.70K | $2.17M | -$1.63M | -$815.41K | $3.32M | $1.66M | -$3.04M | -$1.52M | $6.99M | $3.50M |
Balance Sheet
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $46.01M | $36.63M | $34.87M | $30.26M | $24.98M | $16.55M | $14.20M | $17.63M | $19.31M | $20.62M |
| Current assets | N/A | $18.57K | $25.88K | $37.84K | $764.50K | $29.30K | $32.74K | $36.72K | $45.27K | $2.62M |
| Cash and equivalents | N/A | N/A | N/A | N/A | $710.70K | $617.80K | N/A | N/A | $1.09M | $2.18M |
| Total liabilities | $122.59K | $840.30K | $858.76K | $1.29M | $3.83M | $877.69K | $1.44M | $4.56M | $5.55M | $5.28M |
| Short-term debt | N/A | N/A | N/A | N/A | $715.80K | $627.00K | $1.34M | $4.45M | $4.33M | $2.80M |
| Long-term debt | N/A | N/A | N/A | N/A | N/A | N/A | $1.34M | $4.45M | $4.33M | $2.80M |
| Shareholder equity | $45.89M | $35.79M | $34.01M | $28.97M | $21.15M | $15.68M | $12.77M | $13.06M | $13.76M | $15.34M |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $51.86M | $46.01M | $35.90M | $36.63M | $34.38M | $34.38M | $34.87M | $34.87M | $30.36M | $30.36M | $30.26M | $30.26M |
| Total liabilities | $23.60K | $122.59K | $272.43K | $840.30K | $1.72M | $1.72M | $858.76K | $858.76K | $0 | N/A | $1.29M | $1.29M |
| Shareholder equity | $51.83M | $45.89M | $35.63M | $35.79M | $32.66M | $32.66M | $34.01M | $34.01M | $30.36M | $30.36M | $28.97M | $28.97M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$604.42K | $25.69K | -$3.66M | -$769.30K | -$2.76M | -$2.45M | $3.11M | -$1.32M | -$1.17M | $1.59M |
| Capital expenditures | $0 | $4 | $1 | $4 | $3 | $0 | $0 | $0 | $0 | $0 |
| Free cash flow | -$604.42K | $25.69K | -$3.66M | -$769.30K | -$2.76M | -$2.45M | $3.11M | -$1.32M | -$1.17M | $1.59M |
| Dividends paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $112.10K | $113.99K |
| Investing cash flow | $1.18M | $1.94M | $2.75M | $2.69M | $74.76K | $367.93K | $5.19M | N/A | N/A | N/A |
| Financing cash flow | -$570.94K | -$25.69K | $3.66M | $58.60K | $2.85M | $3.07M | -$3.11M | $226.39K | $1.17M | -$1.59M |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$2.51M | -$297.47K | $467.04K | -$502.05K | -$1.41M | -$446.99K | -$3.79M | -$391.56K | -$2.61M | -$1.44M | -$1.85M |
| Capital expenditures | $0 | $4 | $4 | $3 | $3 | $0 | $0 | $0 | $0 | $0 | $0 |
| Free cash flow | -$2.51M | -$297.47K | $467.04K | -$502.05K | -$1.41M | -$446.99K | -$3.79M | -$391.56K | -$2.61M | -$1.44M | -$1.85M |
Frequently Asked Questions About DXR
What is Daxor's annual revenue?
Daxor reported revenue of $503.42K for the fiscal year ended Dec 31, 2025.
How fast is Daxor's revenue growing?
Revenue was down 76.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -57.0%.
Is Daxor profitable?
Yes. Daxor reported net income of $9.17M for the fiscal year ended Dec 31, 2025, with a net margin of 1821.5%.
How much free cash flow does DXR generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$604.42K minus capital expenditures of $0 produced free cash flow of -$604.42K.
What is DXR's profit margin?
For the fiscal year ended Dec 31, 2025, Daxor reported gross margin of 37.5%, operating margin of 1824.7% and net margin of 1821.5%.
DXR pages: Overview, Financials, Government Contracts